Consolidated Statements of Cash Flows (unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (13,050,033)	$ (5,547,962)
Adjustments to reconcile net loss to net cash
Depreciation and amortization	172,060	129,403
Decrease in right-of-use asset	174,098	184,736
Unrealized foreign currency transaction gain	146,947	274,855
Stock-based compensation	940,307	1,055,581
Change in fair value of liability classified warrants	7,391,591	(5,247,308)
Gain on sale of Vyleesi	(7,823,482)	0
Gain on purchase commitment	0	(1,027,322)
Changes in operating assets and liabilities:
Accounts receivable	569,597	(26,970)
Other receivables	0	(4,674,999)
Prepaid expenses and other assets	1,047,164	(194,776)
Inventories	(1,154,355)	185,203
Accounts payable	(2,710,051)	(2,373,682)
Accrued expenses	(896,812)	(809,395)
Operating lease liabilities	(176,913)	(184,629)
Other liabilities	(1,012,197)	0
Net cash used in operating activities	(16,382,079)	(18,257,265)
CASH FLOWS FROM INVESTING ACTIVITIES:
Maturity of marketable securities	2,992,890	0
Proceeds from sale of Vyleesi	9,500,000	0
Purchases of property and equipment	(37,615)	(264,656)
Net cash provided by (used in) investing activities	12,455,275	(264,656)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of withholding taxes related to restricted stock units	(56,401)	(146,062)
Proceeds from the sale of common stock and warrants,	5,531,266	9,961,462
Payment of finance lease obligations	(52,494)	(49,794)
Proceeds from exercise of warrants	103	0
Net cash provided by financing activities	5,422,474	9,765,606
NET DECREASE IN CASH AND CASH EQUIVALENTS	1,495,670	(8,756,315)
CASH AND CASH EQUIVALENTS, beginning of period	7,989,582	29,939,154
CASH AND CASH EQUIVALENTS, end of period	9,485,252	21,182,839
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	12,487	15,089
Conversion of liability classified warrants upon warrant exercise	$ 2,389,903	$ 0